Comerica Bank cut its stake in shares of Agilent Technologies Inc (NYSE:A) by 20.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 61,616 shares of the medical research company’s stock after selling 15,670 shares during the period. Comerica Bank’s holdings in Agilent Technologies were worth $4,622,000 at the end of the most recent quarter.
Several other institutional investors also recently made changes to their positions in A. Flagship Harbor Advisors LLC raised its position in Agilent Technologies by 139.0% during the second quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock valued at $26,000 after buying an additional 203 shares during the period. Capital Investment Advisory Services LLC acquired a new position in Agilent Technologies during the second quarter valued at $26,000. Liberty Wealth Management LLC acquired a new position in Agilent Technologies during the second quarter valued at $29,000. WealthStone Inc. acquired a new position in Agilent Technologies during the second quarter valued at $31,000. Finally, Coastal Capital Group Inc. acquired a new position in Agilent Technologies during the second quarter valued at $32,000.
Shares of A stock opened at $76.64 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.13 and a quick ratio of 1.72. Agilent Technologies Inc has a fifty-two week low of $62.00 and a fifty-two week high of $82.27. The stock’s 50-day moving average is $75.70 and its two-hundred day moving average is $72.83. The firm has a market cap of $23.38 billion, a P/E ratio of 27.47, a PEG ratio of 1.88 and a beta of 1.42.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend was Monday, September 30th. Agilent Technologies’s dividend payout ratio is 23.66%.
Several research analysts recently weighed in on the company. Bank of America lowered Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price target on the stock. in a research report on Tuesday, July 16th. Robert W. Baird reaffirmed an “outperform” rating and issued a $82.00 target price (up from $79.00) on shares of Agilent Technologies in a research report on Thursday, August 15th. UBS Group lowered Agilent Technologies from a “buy” rating to a “neutral” rating and set a $82.00 target price on the stock. in a research report on Friday, October 18th. Zacks Investment Research lowered Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 target price on the stock. in a research report on Monday, August 19th. Finally, Barclays dropped their target price on Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 9th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $84.00.
In other Agilent Technologies news, Director Heidi Fields sold 4,000 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $78.56, for a total value of $314,240.00. Following the transaction, the director now directly owns 53,287 shares of the company’s stock, valued at approximately $4,186,226.72. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Michael R. Mcmullen sold 24,635 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $77.50, for a total value of $1,909,212.50. The disclosure for this sale can be found here. Insiders sold a total of 32,635 shares of company stock worth $2,507,293 over the last three months.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
See Also: Overbought
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.